The clinical research site (CRS) sector has become one of the most active areas in life sciences M&A. With pharmaceutical companies accelerating development pipelines and ...
For founders of contract research organizations (CROs), pursuing a sale is often the most significant financial and strategic milestone of their careers. A successful transaction ...
The pharmaceutical services industry is undergoing one of the most significant transformations in its history. For decades, Contract Research Organizations (CROs), patient recruitment companies, and ...
Does who you raise capital from actually shape your innovation output? The evidence says yes. And with Objective, Investment Banking & Valuation’s experience in biotech, ...
In recent years, the healthcare landscape has witnessed a transformative shift towards point-of-care testing (POCT), a strategy that brings diagnostic capabilities to the very location ...
The clinical trial support sector has emerged as a critical component of the healthcare landscape, particularly as the demand for innovative therapies continues to rise. ...
Contract Research Organizations (CROs) play a pivotal role in the drug discovery and development process, acting as essential partners for pharmaceutical and biotech companies. Over ...
For life sciences companies, which include software and services for the medical device, pharmaceutical manufacturers, and biotechnology firms, the challenge lies not just in promoting ...
The Life Sciences and Investment Banking sector is defined by rapid technological advancements and regulatory complexities, driving the need for specialized financial expertise. As 2024 ...
